Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
SLU-PP-332 (100mg/capsule), 60 Capsules
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
SLU-PP-332 is a selective pan-estrogen receptor-related receptor (ERR) agonist with demonstrated activity across ERRα, ERRβ, and ERRγ subtypes. The compound exhibits properties related to enhanced mitochondrial biogenesis and oxidative phosphorylation in cellular models. Each unit contains 100mg of the active molecule, supplied in 60-count containers for research applications. The compound is intended exclusively for analytical and laboratory research purposes.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C18H14N2O2 |
|---|---|
| Synonyms | 4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide |
| Molar Mass | 290.32 g/mol |
| CAS Number | 303760-60-3 |
| PubChem CID | 5338394 |
| Total Compound Content | 6,000 mg (100 mg per capsule) |
| Shelf Life | 36 months |
What are estrogen-related receptors (ERRs) and why is SLU-PP-332 significant as a pan-agonist?
ERRα, ERRβ, and ERRγ are orphan nuclear receptors that function as constitutively active transcription factors within the nuclear receptor superfamily. These receptors regulate gene expression through interactions with coactivator proteins and transcriptional regulatory complexes. SLU-PP-332 is notable for exhibiting activity across all three ERR subtypes, making it a valuable research tool for investigating pan-ERR receptor pharmacology, receptor-coactivator interactions, and the coordinated regulation of ERR-dependent transcriptional signaling networks.
What makes SLU-PP-332 useful for ERR receptor research?
SLU-PP-332 possesses a highly selective pan-ERR activity profile, enabling experimental investigation of ERRα-, ERRβ-, and ERRγ-mediated signaling within a single molecular framework. This characteristic allows researchers to examine receptor activation mechanisms, coactivator recruitment processes, transcriptional control systems, and downstream regulatory pathways associated with ERR signaling. Its well-characterized pharmacological profile has established it as an important tool for studies of orphan nuclear receptor biology.
How does SLU-PP-332 differ from other nuclear receptor agonists?
SLU-PP-332 selectively targets the estrogen-related receptor family, whereas many other nuclear receptor agonists act through distinct receptor systems with different signaling architectures and transcriptional regulatory mechanisms. This receptor specificity makes SLU-PP-332 useful for comparative investigations of nuclear receptor pharmacology, receptor-ligand interactions, coactivator biology, and the molecular processes governing receptor-mediated transcriptional regulation.
-
SALE
-
-
-
SALE
-
-
SALE
-
SALE
-
SALE
